← Eichor
Study identifier: NCT06420115 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Can Needle Size Improve Cancer Detection Rate of Transperineal MRI Target Prostate Biopsy Without Affecting Side Effects?

Condition: Prostate Cancer Diagnosis  ·  Sponsor: University Hospital Padova

PhaseNA
Planned participants580
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Differences in terms of diagnostic capability and side effects related to the needle caliber used for prostate biopsy sampling in patients with suspected prostate cancer

This description comes directly from the study's public registry record.

Talk to the study team

Fabio F. Zattoni, MD, PhD  ·  0498212730  ·  fabio.zattoni@unipd.it

Always discuss trial participation with your own doctor first.

Locations (1)

Urology Unit - Padua University HospitalPadua, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06420115